- Home
- CODX vs NXGL Comparison
CODX vs NXGL Comparison
Compare CODX & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- NXGL
- Stock Information
- Founded
- CODX 2013
- NXGL 1997
- Country
- CODX United States
- NXGL United States
- Employees
- CODX N/A
- NXGL N/A
- Industry
- CODX Medical/Dental Instruments
- NXGL Medical/Dental Instruments
- Sector
- CODX Health Care
- NXGL Health Care
- Exchange
- CODX Nasdaq
- NXGL Nasdaq
- Market Cap
- CODX 22.0M
- NXGL 18.9M
- IPO Year
- CODX 2017
- NXGL 2021
- Fundamental
- Price
- CODX $0.31
- NXGL $2.50
- Analyst Decision
- CODX Hold
- NXGL
- Analyst Count
- CODX 1
- NXGL 0
- Target Price
- CODX $1.00
- NXGL N/A
- AVG Volume (30 Days)
- CODX 274.8K
- NXGL 47.2K
- Earning Date
- CODX 03-27-2025
- NXGL 03-24-2025
- Dividend Yield
- CODX N/A
- NXGL N/A
- EPS Growth
- CODX N/A
- NXGL N/A
- EPS
- CODX N/A
- NXGL N/A
- Revenue
- CODX $3,915,160.00
- NXGL $8,688,000.00
- Revenue This Year
- CODX N/A
- NXGL $51.39
- Revenue Next Year
- CODX N/A
- NXGL $36.14
- P/E Ratio
- CODX N/A
- NXGL N/A
- Revenue Growth
- CODX N/A
- NXGL 112.47
- 52 Week Low
- CODX $0.28
- NXGL $1.84
- 52 Week High
- CODX $2.23
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- CODX 29.41
- NXGL 40.08
- Support Level
- CODX $0.32
- NXGL $2.60
- Resistance Level
- CODX $0.39
- NXGL $3.25
- Average True Range (ATR)
- CODX 0.06
- NXGL 0.23
- MACD
- CODX -0.00
- NXGL -0.00
- Stochastic Oscillator
- CODX 18.33
- NXGL 18.28
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.